Fig. 2

All-Cause Inpatient Admissions by Antipsychotic Dose Reduction. Patient claims were analyzed for all-cause inpatient admission for (a) ≥ 10% dose reductions or (b) ≥ 30% dose reductions of antipsychotic medication. Outcomes for case and control cohorts were assessed using Kaplan–Meier analysis and compared using a log-rank test. The number of patients at risk is represented for each time point. Case and control cohorts for ≥10%, N = 19,556 each; case and control cohorts for ≥30%, N = 15,239 each